March 28, 2018 / 2:52 PM / 4 months ago

BRIEF-DiaSorin Earns FDA Clearance Extending Sample Claims For HSV 1 & 2 Test

March 28 (Reuters) - DIASORIN SPA:

* EARNS FDA CLEARANCE EXTENDING SAMPLE CLAIMS FOR SIMPLEXA HSV 1 & 2 DIRECT MOLECULAR TEST

* EXTENSION ADDS CUTANEOUS AND MUCOCUTANEOUS LESION SWABS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below